Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)

Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)

US Patent 11814411 · Granted Nov 14, 2023

Estimated economic value: $82,134,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for reducing immunogenicity of RNA2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Antibodies that bind PSMA and gamma-delta T cell receptors2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Tumor antigens for determining cancer therapy2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Binding agents binding to EpCAM and CD1372025